Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,249,342
-$99,200 QoQ
Shares Held
51,883
+8.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,191
of 2,821 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIDELIS CAPITAL PARTNERS, LLC holds $51,570,809 across 10 Drug Manufacturers - General names. PFE ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
55,734 | $14,154,763 | |
| 2 | LLY |
ELI LILLY & Co
|
11,461 | $13,746,668 | |
| 3 | ABBV |
AbbVie Inc.
|
38,686 | $9,734,945 | |
| 4 | MRK |
Merck & Co., Inc.
|
51,693 | $6,642,550 | |
| 5 | AMGN |
Amgen Inc
|
8,119 | $2,940,052 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
27,994 | $1,613,014 | |
| 7 | PFE |
Pfizer Inc
This page
|
51,883 | $1,249,342 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,859 | $866,566 |
All Filings in PFE
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,249,342 | 51,883 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,348,542 | 48,025 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,549,925 | 62,246 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $825,144 | 32,384 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $661,339 | 27,283 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $399,105 | 15,750 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $650,462 | 24,518 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $747,664 | 25,835 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $687,412 | 24,568 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $670,329 | 24,156 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $560,829 | 19,480 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $659,552 | 19,884 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $824,969 | 22,491 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $869,407 | 21,309 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $612,471 | 11,953 | Shares | Sole | 2023-01-20 | |
| No filing history on record for this holder in this stock. | ||||||